Integris Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Buy
9,085
+1,289
+17% +$300K 0.47% 24
2026
Q1
$1.91M Sell
7,796
-47
-0.6% -$10.9K 0.44% 23
2025
Q4
$1.62M Sell
7,843
-302
-4% -$59.7K 0.37% 26
2025
Q3
$1.51M Hold
8,145
0.37% 25
2025
Q2
$1.24M Buy
8,145
+310
+4% +$47.7K 0.32% 30
2025
Q1
$1.3M Buy
7,835
+15
+0.2% +$2.35K 0.37% 27
2024
Q4
$1.13M Sell
7,820
-971
-11% -$150K 0.32% 29
2024
Q3
$1.42M Buy
8,791
+100
+1% +$15.9K 0.4% 27
2024
Q2
$1.27M Buy
8,691
+1,216
+16% +$181K 0.37% 28
2024
Q1
$1.18M Hold
7,475
0.33% 28
2023
Q4
$1.17M Hold
7,475
0.35% 29
2023
Q3
$1.16M Sell
7,475
-20
-0.3% -$3.3K 0.38% 28
2023
Q2
$1.24M Sell
7,495
-100
-1% -$16.1K 0.44% 23
2023
Q1
$1.18M Buy
7,595
+100
+1% +$16.1K 0.43% 24
2022
Q4
$1.32M Buy
+7,495
New +$1.29M 0.52% 22

Other funds holding JNJ

Integris Wealth Management's JNJ Position: Q2 2026 in Review

Integris Wealth Management increased its Johnson & Johnson (JNJ) stake by 17% in Q2 2026, buying an estimated $300K and bringing the position to 9,085 shares worth $2.31M. The position accounts for 0.47% of the portfolio, ranked #24.

Integris Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Integris Wealth Management held 9,085 shares of Johnson & Johnson worth $2.31M as of Q2 2026.
  • Integris Wealth Management bought 1,289 Johnson & Johnson shares in Q2 2026, an estimated $300K.
  • Johnson & Johnson made up 0.47% of Integris Wealth Management's portfolio in Q2 2026, its #24 holding.
  • Integris Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Integris Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.